Dividend Information About Becton, Dickinson: Everything You Need to Know Before Its Ex-Dividend Date, Sep 8, 2025

Generated by AI AgentAinvest Dividend Digest
Thursday, Sep 4, 2025 10:03 pm ET1min read
BDX--
Aime RobotAime Summary

- Becton, Dickinson (BDX) declared a $1.04/share dividend, payable Sep 30, 2025, with ex-dividend date Sep 8, 2025.

- The payout exceeds its 10-year average of $0.30/share and follows a similar June 2025 dividend, showing consistent distribution.

- Recent challenges include Q3 revenue misses due to weak research/diagnostics demand, countered by expanded "Love Your Limbs" health initiatives.

- The company aims for 5.5%+ 2025 revenue growth through AI-driven patient monitoring and minimally invasive surgical innovations.

- Despite a +0.78% weekly stock rise, technical indicators remain weak, urging cautious monitoring of strategic execution.

Becton, Dickinson and Company (BDX) has announced a cash dividend of $1.04000 per share, with the ex-dividend date set for Sep 8, 2025. The dividend was declared on Jul 22, 2025, and will be paid out on Sep 30, 2025. This payout is significantly higher than the average of the last 10 dividend per share amounts, which stood at approximately $0.30120. The company’s most recent dividend, issued on Jun 30, 2025, was also a cash dividend of $1.04000 per share, indicating a consistent payout pattern in recent months.

Over the past week, BectonBDX--, Dickinson has been the subject of several noteworthy developments. Recently, the company expanded its efforts in peripheral artery disease awareness through its “Love Your Limbs” community screening initiative, launched on Sep 2, 2025. This move highlights BD’s ongoing commitment to public health and community engagement. Additionally, since the last update, the firm has faced some headwinds, as it recently reported revenue that missed expectations in the previous quarter, attributed to softness in its research instrument and diagnostics segments. These challenges underscore the need for continued strategic focus and operational adaptability.

Looking ahead, analysts have indicated that the company is pursuing a forward-looking strategy aimed at driving growth. As of late, BD has outlined a 2025 roadmap that targets revenue growth of 5.5% or more, driven by AI-integrated patient monitoring solutions and innovations in minimally invasive surgical tools. These initiatives align with the growing trend in home healthcare and reflect BD’s strategic pivot to capitalize on emerging market opportunities.

In terms of market performance, BDXBDX-- has shown a mixed technical and fundamental outlook. Over the past week, the stock has experienced a modest increase of +0.78%, although it remains in a weak technical state. This divergence between technical indicators and company fundamentals suggests that investors should proceed with caution and closely monitor the company’s upcoming performance.

In conclusion, Becton, Dickinson continues to demonstrate strategic ambition and operational resilience, even amid recent challenges. The ex-dividend date of Sep 8, 2025, marks the final day for investors to purchase the company’s stock and qualify for the $1.04000 per share dividend. Any shares acquired after this date will not be eligible for the upcoming payout.

Sip from the stream of US stock dividends. Your income play.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet